Joshua Schafer, CCO of ZeVRA Therapeutics ($ZVRA), made two open market sales of company stock in the last year, totaling $126,300. His most recent sale occurred on February 3, 2026. These transactions rank 9,234th among 11,678 insiders in our database by sale value, well below the average of $8.6 million across 6.4 transactions per insider. Schafer made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO | S | Common Stock | 10500 | $9.19 | 62,278.0000 | 56,783,000 | 14.43% | 0.02% |
| Jan. 30, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO | M | Common Stock | 11333 | $0.00 | 40,819.0000 | 56,783,000 | 38.44% | 0.02% |
| Jan. 30, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO | S | Common Stock | 3375 | $8.83 | 37,444.0000 | 56,783,000 | 8.27% | 0.01% |
| Jan. 31, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO | M | Common Stock | 35334 | $0.00 | 72,778.0000 | 56,783,000 | 94.36% | 0.06% |
| Jan. 29, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO | A | Restricted Stock Unit | 37500 | $0.00 | 37,500.0000 | 56,783,000 | 9999.99% | 0.07% |
| Jan. 29, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 56,783,000 | 9999.99% | 0.13% |
| Jan. 31, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO | M | Restricted Stock Unit | 35334 | $0.00 | 35,333.0000 | 56,783,000 | 50.00% | 0.06% |
| Jan. 30, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO | M | Restricted Stock Unit | 11333 | $0.00 | 22,667.0000 | 56,783,000 | 33.33% | 0.02% |
| Feb. 13, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | S | Common Stock | 10500 | $7.86 | 29,486.0000 | 47,808,817 | 26.26% | 0.02% |
| Dec. 23, 2024 | Shuttle Pharmaceuticals Holdings, Inc. | $SHPH | Schafer Joshua | Director | A | Common Stock | 209790 | $0.00 | 210,004.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2024 | Shuttle Pharmaceuticals Holdings, Inc. | $SHPH | Schafer Joshua | Director | A | Common Stock | 209790 | $0.00 | 210,004.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | M | Common Stock | 35333 | $0.00 | 39,986.0000 | 47,808,817 | 759.36% | 0.07% |
| Jan. 31, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | M | Restricted Stock Unit | 35333 | $0.00 | 70,667.0000 | 47,808,817 | 33.33% | 0.07% |
| Jan. 30, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | A | Stock Option (right to buy) | 68000 | $0.00 | 68,000.0000 | 47,808,817 | 9999.99% | 0.14% |
| Jan. 30, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | A | Restricted Stock Unit | 34000 | $0.00 | 34,000.0000 | 47,808,817 | 9999.99% | 0.07% |
| Jan. 31, 2024 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | A | Restricted Stock Unit | 106000 | $0.00 | 106,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 5, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | P | Common Stock | 500 | $5.13 | 3,500.0000 | 0 | 16.67% | 0.00% |
| May 19, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | P | Common Stock | 1000 | $5.42 | 3,000.0000 | 0 | 50.00% | 0.00% |
| March 14, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | P | Common Stock | 2000 | $4.61 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Schafer Joshua | CCO & EVP, Bus. Development | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |